Search - tctmd.com

Displaying 501 - 520 of 2956

Sort: Relevancy | Date

Presentation TCT 2017

How to Manage Coronary Obstruction (Threatened or Actual) During TAVR

Presenter: Torsten P. Vahl, Mathew Williams

November 01, 2017

Presentation TCT 2017

Featured Lecture: The Societal and Academic Imperative for Complete Data Sharing at all Levels

Presenter: Robert A. Harrington, Richard E. Kuntz, Eric D. Peterson

November 01, 2017

Presentation TCT 2017

Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Pilot Clinical Study

Presenter: Dariusz Dudek, Cindy L. Grines, Liansheng Wang

November 01, 2017

Presentation TCT 2017

Training in Endovascular Intervention

Presenter: Gary M. Ansel, Sahil A. Parikh

November 01, 2017

Presentation TCT 2017

TAVR for Severe AS and Chronic Kidney Disease

Presenter: Gregory P. Fontana, Saif Anwaruddin

November 01, 2017

Presentation TCT 2017

Novel Crossing System for CTO Recanalization

Presenter: Emmanouil S. Brilakis, Christopher E. Buller

November 01, 2017

Presentation TCT 2017

Aortic Arch Electrical Stimulation for Heart Failure

Presenter: Jozef Bartunek

November 01, 2017

Presentation TCT 2017

Highlights From the Updated PAD Guidelines and AUC

Presenter: Gary M. Ansel, Sahil A. Parikh, Steven R. Bailey

November 01, 2017

Presentation TCT 2017

The Potential for Neuromodulation in Heart Failure

Presenter: Felix Mahfoud

November 01, 2017

Presentation TCT 2017

TAVR for Severe AS Due to Bicuspid Aortic Valve Disease

Presenter: Gregory P. Fontana, Alexander Lauten

November 01, 2017

Presentation TCT 2017

24-month Results From a First-In-Human Data on the Paclitaxel Drug Coated Chocolate Coronary PTCA Balloon Catheters in De-Novo Coronary Lesions

Presenter: Emmanouil S. Brilakis, Christopher E. Buller, Georgios Bouras

November 01, 2017

Presentation TCT 2017

TAVR for Low-gradient AS (Normal and Reduced LVEF) Diagnosis and Management

Presenter: Gregory P. Fontana, Julinda Mehilli

November 01, 2017

Presentation TCT 2017

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 2-Year Clinical Follow-Up

Presenter: Emmanouil S. Brilakis, Christopher E. Buller, Pieter R. Stella

November 01, 2017

Presentation TCT 2017

Devices for Cardio-Renal Failure: The Future of Heart Failure and Shock Therapies?

Presenter: Navin K. Kapur

November 01, 2017

Presentation TCT 2017

TAVR for Severe AS With a Small Aortic Annulus

Presenter: Gregory P. Fontana, Josep Rodés-Cabau

November 01, 2017

Presentation TCT 2017

Radial Hemostasis Is Facilitated With a Potassium Ferrate Hemostatic Patch(Statseal): Preliminary Results From the Randomized Controlled Statseal With TR Band Assessment Trial (STAT)

Presenter: Emmanouil S. Brilakis, Christopher E. Buller, Arnold Seto

November 01, 2017

Presentation TCT 2017

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Presenter: James E. Udelson

November 01, 2017

Presentation TCT 2017

The Most Important Clinical Trials of the Past Decade in Vascular Intervention

Presenter: Gary M. Ansel, Sahil A. Parikh, Andrew J. Klein

November 01, 2017

Presentation TCT 2017

TAVR for Severe AS and Hypertrophic Cardiomyopathy

Presenter: Gregory P. Fontana, Amar Krishnaswamy

November 01, 2017

Presentation TCT 2017

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

Presenter: Angeles Alonso Garcia

November 01, 2017

Advertisement

How to Manage Coronary Obstruction (Threatened or Actual) During TAVR

Featured Lecture: The Societal and Academic Imperative for Complete Data Sharing at all Levels

Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Pilot Clinical Study

Training in Endovascular Intervention

TAVR for Severe AS and Chronic Kidney Disease

Novel Crossing System for CTO Recanalization

Aortic Arch Electrical Stimulation for Heart Failure

Highlights From the Updated PAD Guidelines and AUC

The Potential for Neuromodulation in Heart Failure

TAVR for Severe AS Due to Bicuspid Aortic Valve Disease

24-month Results From a First-In-Human Data on the Paclitaxel Drug Coated Chocolate Coronary PTCA Balloon Catheters in De-Novo Coronary Lesions

TAVR for Low-gradient AS (Normal and Reduced LVEF) Diagnosis and Management

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 2-Year Clinical Follow-Up

Devices for Cardio-Renal Failure: The Future of Heart Failure and Shock Therapies?

TAVR for Severe AS With a Small Aortic Annulus

Radial Hemostasis Is Facilitated With a Potassium Ferrate Hemostatic Patch(Statseal): Preliminary Results From the Randomized Controlled Statseal With TR Band Assessment Trial (STAT)

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

The Most Important Clinical Trials of the Past Decade in Vascular Intervention

TAVR for Severe AS and Hypertrophic Cardiomyopathy

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content